ZATTI, SUSI
 Distribuzione geografica
Continente #
NA - Nord America 815
AS - Asia 116
EU - Europa 115
OC - Oceania 1
Totale 1.047
Nazione #
US - Stati Uniti d'America 812
CN - Cina 104
FI - Finlandia 36
IT - Italia 35
SE - Svezia 24
DE - Germania 9
VN - Vietnam 9
AT - Austria 3
CA - Canada 3
IN - India 3
CH - Svizzera 2
FR - Francia 2
GB - Regno Unito 2
IE - Irlanda 2
NZ - Nuova Zelanda 1
Totale 1.047
Città #
Woodbridge 124
Chandler 120
Fairfield 83
Ann Arbor 71
Houston 54
Ashburn 45
Cambridge 38
Wilmington 33
Beijing 27
Helsinki 20
Medford 20
Nanjing 20
Princeton 20
Seattle 20
Des Moines 19
New York 18
Padova 12
Boardman 11
Jinan 11
San Diego 10
Dong Ket 9
Cagliari 6
Hebei 6
Tianjin 5
Changsha 4
Nanchang 4
Milan 3
Roxbury 3
Shenyang 3
Dublin 2
Jiaxing 2
Kunming 2
Los Angeles 2
Mississauga 2
Munich 2
Norwalk 2
Pune 2
Redwood City 2
Turin 2
Vienna 2
Birmingham 1
Brunswick 1
Costa Mesa 1
Dearborn 1
Hangzhou 1
Hefei 1
Kilburn 1
Murfreesboro 1
Ningbo 1
Nuremberg 1
Pinehaven 1
Rockville 1
Solesino 1
Taiyuan 1
Taizhou 1
Torino 1
Toronto 1
Treviso 1
Washington 1
Wenzhou 1
Zhengzhou 1
Totale 862
Nome #
Micro-Arrayed Human Embryonic Stem Cells-Derived Cardiomyocytes for in vitro Functional Assay 100
Engineering a 3D in vitro model of human skeletal muscle at the single fiber scale 80
Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance 71
Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne Muscular Dystrophy patient-derived cardiomyocytes. 63
Skeletal muscle differentiation on a chip shows human donor mesoangioblasts’ efficiency in restoring dystrophin in a duchenne muscular dystrophy model 63
Culture of Human Embryonic Stem Cell-derived Embryoid Bodies in multiscale bioreactors for optimal control of cardiac differentiation 59
Engineering an in vitro model of human muscle dystrophy for highthroughput screenings and development of therapeutic strategies 56
Dystrophin expression restoration by human artificial chromosome in cardiomyocytes-derived from DMD patient hiPS cells 55
An in vitro model for cardiac cell therapy: coupling a microfluidic platform with arrayedhuman embryonic stem cells-derived cardiomyocytes for screening pathological conditions 52
Microscale in vitro model for screening pathological conditions on human embryonic stem cell-derived cardiomyocytes 52
Muscle tissue micro engineering 51
Substrate-driven maturation of human pluripotent stem cell-derived cardiomyocytes 48
Mesoangioblasts contribution to dystrophin restoration in a human in vitro model 48
Microscale in vitro technologies for screening pathological conditions on human embryonic stem cells-derived cardiomyocytes: an in vitro model for cardiac cell therapy 47
Micro-engineered skeletal and cardiac muscle for Duchenne muscular dystrophy in vitro models 45
Controlled cardiac differentiation of human embryonic stem cell-derived embryoid bodies in scalable bioreactors 41
Micropatterning topology on soft substrates affects myoblasts proliferation and differentiation 33
A human in vitro model of dystrophic skeletal muscle for testing different stem cells capability in restoring dystrophin expression 30
Engineering an in vitro model of human muscle dystrophy for highthroughput screenings and development of therapeutic strategies 29
Complete genetic correction of cardiomyocytes from dystrophic patient-derived human induced pluripotent stem cells 28
Totale 1.051
Categoria #
all - tutte 3.690
article - articoli 1.658
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 7 14 15
2019/2020172 34 3 0 3 12 5 15 18 10 46 24 2
2020/202195 8 3 7 11 6 4 3 9 14 6 6 18
2021/2022172 3 36 16 10 4 16 7 17 5 3 10 45
2022/2023253 34 30 10 24 41 34 2 16 43 6 9 4
2023/2024124 3 14 24 13 12 32 7 10 3 6 0 0
Totale 1.051